Epidemiological trends and trajectories of MAFLD-associated hepatocellular carcinoma 2002–2033: the ITA.LI.CA database
Alessandro Vitale(University of Padua), Fabio Farinati(University of Padua)
Cited by 164
Related Papers
Abnormal Liver Function Tests in Patients With COVID‐19: Relevance and Potential Pathogenesis
|Hepatology|2020|302
Personalised management of patients with hepatocellular carcinoma: a multiparametric therapeutic hierarchy concept
|The Lancet Oncology|2023|184
Recurrence of hepatocellular carcinoma after direct acting antiviral treatment for hepatitis C virus infection: Literature review and risk analysis
|Digestive and Liver Disease|2018|61